NAD+ Injections for Energy: What the Evidence Actually Shows
The chemistry links NAD+ to energy. The human evidence on injections is far thinner than the marketing.
Words by the editors ·
Sponsored
Short answer: no controlled trial has shown that NAD+ injections raise energy in people. What exists is a handful of small, uncontrolled or exploratory reports on injected or intravenous NAD+, and reviewers of that literature call it preliminary and insufficient to support routine use.14 The better-controlled human trials involve oral precursors, not injections, and they have not shown a reliable change in fatigue either.25 This page sets out what the evidence says, what injections are and are not, and what to ask a prescriber.
It is a companion to our explainer What Is NAD+? and our look at whether NAD+ supplements are worth it.
In brief
- A 2026 review found human evidence on intravenous NAD+ is sparse, mostly small uncontrolled studies, and insufficient to support routine use.1
- In a 58-person randomized trial in long-COVID, NR raised NAD+ about 2.6- to 3.1-fold but did not significantly improve fatigue versus placebo.2
- Reported side effects of intravenous NAD+ include nausea, cramping, flushing and chest discomfort; long-term safety data are lacking.1
- Compounded NAD+ injections are not FDA-approved, and the FDA does not verify the safety, effectiveness or quality of compounded drugs.3
Do NAD+ injections improve energy?
There is no trial showing it. A 2026 narrative review of intravenous NAD+ and NAD+ precursors found that the available human evidence "is sparse and consists primarily of small uncontrolled studies, observational investigations, and isolated case reports." Short-term administration was linked to temporary rises in circulating NAD+ and changes in some biomarkers, and a few exploratory reports described better sleep or neurological symptoms. The reviewers say the clinical meaning of those findings is uncertain because of small samples, no placebo groups and short follow-up, and they conclude the evidence is insufficient to support routine clinical or wellness use.1
A second 2026 critical review reached a similar view of intravenous "longevity" infusions that include NAD+. It found transient changes in oxidative markers and "modest improvements in fatigue syndromes" in small series, mostly in disease-specific or cosmetic settings rather than healthy people, with few placebo-controlled trials and conflicting results. Its authors say such therapy should be regarded as experimental.4
Both reviews cover intravenous NAD+. We found no review that isolates the injection routes sold by online clinics, so none of this evidence can be assumed to carry over, for or against.
Why is NAD+ linked to energy at all?
The link is chemistry. NAD+ is a coenzyme that cells use in the reactions that turn food into usable energy, and it is involved in DNA repair and stress signaling.1 That makes it a plausible target, and animal studies of NAD+-boosting molecules have been encouraging.6 A plausible target is not a proven treatment. The 2026 review also notes that recent large human datasets show whole-blood NAD+ does not fall with healthy aging by itself, which weakens the idea that a typical tired adult is simply "low".1
What do the controlled trials of NAD+ boosters show?
The randomized work is almost all on oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), or on the oral form NADH. It tells us whether raising NAD+ changes how people feel.
| Evidence | Who and what | What it found |
|---|---|---|
| Wu 20252 | 58 adults with long-COVID; NR 2,000 mg/day, double-blind, placebo-controlled, 24 weeks; funded in part by an NR maker | NAD+ rose about 2.6- to 3.1-fold, but no significant difference from placebo in fatigue severity, sleep, mood or cognition; 51% dropout in the main NR group by week 20 |
| Dollerup 20187 | 40 obese men; NR 2,000 mg/day for 12 weeks | No improvement in insulin sensitivity, energy expenditure or body composition |
| Prokopidis 20258 | Meta-analysis in adults over 60 | NMN had no significant effect on muscle mass, grip strength or gait speed |
| Gindri 20245 | Systematic review of 10 randomized trials, 489 participants, of NAD+ and NADH products, including chronic fatigue syndrome | Well tolerated, with muscle pain, nervous disorders, fatigue, sleep disturbance and headaches among reported side effects; authors say benefits in specific conditions still need study |
The long-COVID trial is the closest match to "does boosting NAD+ ease fatigue". It raised NAD+ clearly and still found no significant fatigue difference against placebo. Its authors noted exploratory within-group improvements after 10 weeks of NR and called for larger trials, but a within-group change without a placebo comparison cannot separate the supplement from time and expectation.2
What side effects are reported?
The 2026 review of intravenous NAD+ lists nausea, cramping, flushing and chest discomfort, and says long-term safety data are lacking.1 The oral-product review found that every included trial reported some side effects, most commonly muscle pain, nervous disorders, fatigue, sleep disturbance and headache, none judged a serious risk to participants.5 Nobody has data on years of injections. Tell a prescriber about every medicine, any heart symptoms and any pregnancy or cancer history before starting.
What are prescription NAD+ injections?
NAD+ injections sold online are compounded. A compounded drug is made by a pharmacy for an individual patient, and the FDA states that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before they are marketed.3 That separates them from dietary supplements, which are also not FDA-approved before sale, but are regulated as foods and sold without a prescription.9
Our pick: NAD+ injections from Vea Health Sponsored
Because this page answers a question about NAD+ injections, we feature Vea Health's, and we do so because we have a financial relationship with Vea Health. That is the only basis for the placement. No study shows that Vea's NAD+ injections, or any NAD+ injection, increases energy, and we make no claim that they do.
Vea Health says it offers NAD+ injections prescribed by a licensed clinician after an online health questionnaire and filled by a state-licensed U.S. compounding pharmacy, and that you are not charged unless a clinician approves the prescription.10 They are compounded, so they are not FDA-approved.3 The page does not state the dose, schedule or injection route, so ask the prescriber for all three. It suits an adult who has already read the evidence above, accepts that the benefit is unproven, and wants a clinician to review their history first.
What should you ask before trying NAD+ injections?
- What specific outcome are we aiming for, and how will we decide it did or did not happen?
- Has persistent tiredness been checked first? Sleep problems, low thyroid hormone, anemia, depression, medicines and low testosterone are all common causes that have their own treatments.
- What are the dose, the injection route and the schedule, and when do we stop and reassess?
- Which pharmacy compounds it, and how is it labeled and stored?
- Which side effects should prompt me to stop and call?
If tiredness is the main concern, our feature on what happens to a man's body after 40 covers the better-supported levers first.
Bottom line
The honest answer to "do NAD+ injections give you energy" is that nobody has shown it. The mechanism is real, the oral-precursor trials raise blood NAD+ without a clear effect on how people feel, and the injection evidence is too thin to judge. A clinician can still discuss it with you as an unproven option, but it should come after the basics, not before.
Questions
Do NAD+ injections give you energy?
No controlled trial has shown that they do. A 2026 review of intravenous NAD+ found the human evidence sparse and mostly small uncontrolled studies, and called it insufficient to support routine wellness use.
How long do NAD+ injections take to work?
No study establishes a timeline for any energy benefit, because no controlled trial shows one. Anything a clinic promises on timing is not backed by published trials we could find.
Are NAD+ injections safe?
Reported effects of intravenous NAD+ include nausea, cramping, flushing and chest discomfort, and long-term safety data are lacking. A prescriber should review your history and medicines first.
Are NAD+ injections FDA-approved?
Compounded NAD+ injections are not FDA-approved. The FDA states it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.
Do NAD+ supplements work better than injections?
No trial compares them for energy. Oral precursors raise blood NAD+ in trials but have not shown a consistent benefit on fatigue, muscle or metabolism.
Also in this edition
Part of our guide: Aging Well: NAD+, Exercise and the Male Body After 40
Notes
- Alangari A, et al. Narrative review of intravenous NAD(+) and NAD(+) precursors in wellness and translational medicine. Front Aging. 2026. PubMed 42787547.
- Wu CY, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. EClinicalMedicine. 2025. PubMed 41357333.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Godic A, Townsend J. Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility. Acta Dermatovenerol Alp Pannonica Adriat. 2026. PubMed 41915584.
- Gindri IM, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024. PubMed 37971292.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018. PubMed 29514064.
- Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018. PubMed 29992272.
- Prokopidis K, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025. PubMed 40275690.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements.
- Vea Health. NAD+ injections intake. Accessed October 9, 2026.